Display options
Cite
Febbo PG, Martin AM, Scher HI, et al. Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases. Clin Pharmacol Ther. 2020;107(4):730-734doi: 10.1002/cpt.1747.
Febbo, P. G., Martin, A. M., Scher, H. I., Barrett, J. C., Beaver, J. A., Beresford, P. J., Blumenthal, G. M., Bramlett, K., Compton, C., Dittamore, R., Eberhard, D. A., Edelstein, D., Godsey, J., Gruen, A., Hanlon, S. E., Hicks, J., Hovelson, D., Hullings, M., Johann, D., Johnson, J., Kolatkar, A., Kuhn, P., Levine, R., Martini, J. F., Miller, D. P., Moore, C., Moy, B., Pathak, A., Philip, R., Reese, D., Royalty, W., Ryder, M., Sakul, H., Salvatore, L. M., Schade, A., Silvestro, A., Simmons, J. K., Simons, J., Singh Bhan, S., Smalley, M. D., Somiari, S. B., Talasaz, A., Tewari, M., Tseng, H. R., Vinson, J., Wells, W., Welsh, A., Grossman, R. L., Lee, J. S. H., & Leiman, L. C. (2020). Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases. Clinical pharmacology and therapeutics, 107(4), 730-734. https://doi.org/10.1002/cpt.1747
Febbo, Phillip G, et al. "Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases." Clinical pharmacology and therapeutics vol. 107,4 (2020): 730-734. doi: https://doi.org/10.1002/cpt.1747
Febbo PG, Martin AM, Scher HI, Barrett JC, Beaver JA, Beresford PJ, Blumenthal GM, Bramlett K, Compton C, Dittamore R, Eberhard DA, Edelstein D, Godsey J, Gruen A, Hanlon SE, Hicks J, Hovelson D, Hullings M, Johann D, Johnson J, Kolatkar A, Kuhn P, Levine R, Martini JF, Miller DP, Moore C, Moy B, Pathak A, Philip R, Reese D, Royalty W, Ryder M, Sakul H, Salvatore LM, Schade A, Silvestro A, Simmons JK, Simons J, Singh Bhan S, Smalley MD, Somiari SB, Talasaz A, Tewari M, Tseng HR, Vinson J, Wells W, Welsh A, Grossman RL, Lee JSH, Leiman LC. Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases. Clin Pharmacol Ther. 2020 Apr;107(4):730-734. doi: 10.1002/cpt.1747. Epub 2020 Feb 04. PMID: 32017048; PMCID: PMC7158216.
Copy Download .nbib Format: NLM
Share it on

Clin Pharmacol Ther. 2020 Apr;107(4):730-734. doi: 10.1002/cpt.1747. Epub 2020 Feb 04.

Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.

Clinical pharmacology and therapeutics

Phillip G Febbo, Anne-Marie Martin, Howard I Scher, J Carl Barrett, Julia A Beaver, Paul J Beresford, Gideon M Blumenthal, Kelli Bramlett, Carolyn Compton, Ryan Dittamore, David A Eberhard, Daniel Edelstein, James Godsey, Andrew Gruen, Sean E Hanlon, James Hicks, Daniel Hovelson, Melanie Hullings, Donald Johann, Justin Johnson, Anand Kolatkar, Peter Kuhn, Rebecca Levine, Jean-Francois Martini, Daniel P Miller, Carissa Moore, Bryan Moy, Anand Pathak, Reena Philip, David Reese, Wendy Royalty, Matthew Ryder, Hakan Sakul, Lea M Salvatore, Andrew Schade, Angela Silvestro, John K Simmons, Jonathan Simons, Seema Singh Bhan, Matthew D Smalley, Stella B Somiari, AmirAli Talasaz, Muneesh Tewari, Hsian-Rong Tseng, Jake Vinson, Walt Wells, Allison Welsh, Robert L Grossman, Jerry S H Lee, Lauren C Leiman

Affiliations

  1. Illumina, San Diego, California, USA.
  2. Novartis Pharmaceuticals, East Hanover, New Jersey, USA.
  3. Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  4. AstraZeneca, Waltham, Massachusetts, USA.
  5. Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Springs, Maryland, USA.
  6. Biodesix, Inc, Boulder, Colorado, USA.
  7. Thermo Fisher Scientific, Austin, Texas, USA.
  8. College of American Pathologists, Scottsdale, Arizona, USA.
  9. Epic Sciences, San Diego, California, USA.
  10. Sysmex Inostics, Baltimore, Maryland, USA.
  11. Seven Bridges Genomics, Boston, Massachusetts, USA.
  12. Office of the Director, National Cancer Institute, Bethesda, Maryland, USA.
  13. University of Southern California, Los Angeles, California, USA.
  14. University of Michigan, Ann Arbor, Michigan, USA.
  15. University of Arkansas, Little Rock, Arkansas, USA.
  16. Prostate Cancer Foundation, Los Angeles, California, USA.
  17. Pfizer, San Diego, California, USA.
  18. Center for Translational Data Science, University of Chicago, Chicago, Illinois, USA.
  19. Streck, Inc., La Vista, Nebraska, USA.
  20. Center for Device and Radiological Health, US Food and Drug Administration, Silver Springs, Maryland, USA.
  21. Provista Diagnostics Inc, New York, New York, USA.
  22. Open Commons Consortium, Chicago, Illinois, USA.
  23. Eli Lilly and Company, Indianapolis, Indiana, USA.
  24. Novartis Pharmaceuticals, Cambridge, Massachusetts, USA.
  25. Personal Genome Diagnostics, Baltimore, Maryland, USA.
  26. Foundation Medicine, Cambridge, Massachusetts, USA.
  27. CytoLumina, Inc, Los Angeles, California, USA.
  28. CSSIMMW (Windber Research Institute), Windber, Pennsylvania, USA.
  29. Guardant Health, Inc, Redwood City, California, USA.
  30. Prostate Cancer Clinical Trials Consortium, New York, New York, USA.
  31. BloodPAC, Chicago, Illinois, USA.

PMID: 32017048 PMCID: PMC7158216 DOI: 10.1002/cpt.1747

[No abstract available.]

References

  1. Clin Pharmacol Ther. 2017 May;101(5):589-592 - PubMed
  2. Clin Cancer Res. 2012 Mar 15;18(6):1515-23 - PubMed
  3. Clin Cancer Res. 2008 Oct 1;14(19):5967-76 - PubMed
  4. J Clin Oncol. 2010 Feb 1;28(4):698-704 - PubMed
  5. Arch Pathol Lab Med. 2019 Nov;143(11):1346-1363 - PubMed
  6. Clin Cancer Res. 2012 Mar 15;18(6):1540-6 - PubMed
  7. Clin Cancer Res. 2012 Mar 15;18(6):1524-30 - PubMed
  8. Semin Cancer Biol. 2018 Oct;52(Pt 2):26-38 - PubMed
  9. Clin Biochem. 2016 Dec;49(18):1354-1360 - PubMed
  10. Arch Pathol Lab Med. 2018 Oct;142(10):1242-1253 - PubMed

MeSH terms

Publication Types

Grant support